Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Gregory Schwartz and Demetria Bolden.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.986 |
|
|
|
-
Bolden DM, Richardson V, Salahuddin T, Henderson K, Hess PL, Raghavan S, Saxon DR, Ho PM, Waldo SW, Schwartz GG. Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system. Am J Prev Cardiol. 2025 Jun; 22:100966.
Score: 0.986